drug

Mecta spectrum 5000Q device

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Behman Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Low Pulse Amplitude Seizure Therapy (LAP-ST Study)
NCT02928159Phase 1Completed

KOLs & investigators

2
Nagy A Youssef, MD, PhDKOL score 5
Emad Sidhom

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Behman Hospital
company
trial
Low Pulse Amplitude Seizure Therapy (LAP-ST Study)
PHASE1
trial
indication
Mood Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Mood Disorders
indication
Psychotic Disorders
indication
KOL
Nagy A Youssef, MD, PhD
KOL score 5
person
Emad Sidhom
KOL score —
person